Pain Management News and Research

RSS

Free medical application for health care professionals

Presents the most commonly asked pain management and/or addiction medicine questions, and presents them in easy-to-view, brief video vignettes. You can view 30-second to 2-minute videos in pharmacotherapy; assessment; abuse, misuse & addiction; best practices; and legal issues.

22 Oct 2009

Women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts: Study

In the first study to look at sex-specific pain prevalence in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans, researchers from the VA Connecticut Healthcare System and the Yale University School of Medicine found women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts. Approximately 60% of OEF/OIF Veterans were assessed with pain during the study period.

21 Oct 2009

Apotex to market Hisamitsu's Fentanyl Transdermal System for chronic pain management

Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical Company of Japan. Apotex will sell to the U.S. healthcare market, Hisamitsu's recently FDA approved matrix Fentanyl Transdermal System for the management of chronic pain.

21 Oct 2009

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

20 Oct 2009

Hydra Biosciences and Cubist Pharmaceuticals join to develop novel ion channel drugs

Hydra Biosciences today announced that they have entered into an agreement with Cubist Pharmaceuticals, Inc. for a joint collaboration to develop novel ion channel drugs.

20 Oct 2009

Copper bracelets and magnetic wrist straps are ineffective in relieving arthritis pain, says study

Copper bracelets and magnetic wrist straps are ineffective in relieving arthritis pain, according to a new study led by a University of York academic.

19 Oct 2009

Endoscopic surgery reduces postoperative discomfort and recovery time

Endoscopic surgery has steadily gained in popularity since it was developed in the 1980s. Dr. Richard Siegfried has teamed with Dr. Louis Quartararo one of only a handful of surgeons who have been trained to perform endoscopic surgery on the spine.

14 Oct 2009

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

13 Oct 2009

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

The University of Kansas Hospital has deployed NeoFax(®) from Thomson Reuters to provide physicians, nurses, and pharmacy staff in its neonatal intensive care unit with electronic drug dosing, interaction checking, and reference information.

13 Oct 2009

Acupuncture can help prevent caesarean delivery

Debra Betts, an international expert, educator and author of the Essential Acupuncture for Pregnancy and Childbirth will be presenting a workshop for dulas, midwives and acupuncturists in Vancouver, October 13th and 14th.

13 Oct 2009

B. Braun Medical announces agreement with HealthTrust to provide pain management products

B. Braun Medical Inc. (B. Braun) has announced an expanded agreement with HealthTrust Purchasing Group (HealthTrust) to provide pain management products to HealthTrust's membership.

From B. Braun Melsungen AG 12 Oct 2009

QRxPharma signs contractual agreement with Patheon

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid(TM) formulation (MoxDuo(TM)CR). MoxDuo(TM)CR is designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic).

12 Oct 2009

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona.

12 Oct 2009

VitalWear partners with XBACK Bracing Services to deliver innovative products

VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that they have formed a partnership with XBACK Bracing Services (www.xbackbrace.com) revolutionizing the bracing and thermal therapy markets. (www.thexbackvwsolution.com)

12 Oct 2009

Kimberly-Clark to acquire I-Flow Corporation

Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.

9 Oct 2009

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

8 Oct 2009

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test.

8 Oct 2009

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.

6 Oct 2009

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

Zynex, Inc. a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has obtained accreditation as a Medicare DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) supplier, as required to maintain its status as provider to Medicare and several private health insurance companies.

5 Oct 2009

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

5 Oct 2009

Pain Management News and Research

Free medical application for health care professionals

Women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts: Study

Apotex to market Hisamitsu's Fentanyl Transdermal System for chronic pain management

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Hydra Biosciences and Cubist Pharmaceuticals join to develop novel ion channel drugs

Copper bracelets and magnetic wrist straps are ineffective in relieving arthritis pain, says study

Endoscopic surgery reduces postoperative discomfort and recovery time

Meda Pharmaceuticals introduces Onsolis for treating breakthrough cancer pain

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

Acupuncture can help prevent caesarean delivery

B. Braun Medical announces agreement with HealthTrust to provide pain management products

QRxPharma signs contractual agreement with Patheon

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

VitalWear partners with XBACK Bracing Services to deliver innovative products

Kimberly-Clark to acquire I-Flow Corporation

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Dominion Diagnostics enhances laboratory testing procedure for chronic opioid pharmacotherapy

Phase 3 results of Transdel's lead topical pain drug Ketotransdel announced

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News